{"id":"622ce5ab-b136-479d-8631-33ec3aa0491e","slug":"recall-2024-08-05-quantum-surgical","kind":"recall","headline":"FDA Class 2 recall of Epione needle guide component due to rust","summary":"Quantum Surgical issued an urgent field safety notice for 2 Epione units in Florida after discovering rust on a component (central axis) inside the Needle Guide product (product number 02-0027). The affected units were returned, repaired, and replaced. Recall was completed by October 2024.","occurredAt":"2024-08-05T12:00:00.000Z","reviewStatus":"reviewed","modelId":"ba28973f-6a33-4cce-a22f-d34a99443937","deploymentId":"3c35444a-6010-458e-b1e4-76fd2f5b572d","companyId":"cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed","dataCenterId":null,"aliases":[],"collisionRisk":"none","reviewNote":null,"severity":"moderate","rootCauseCategory":null,"rootCauseDetail":null,"affectedUnitsCount":null,"affectedUnitsBasis":null,"remediationStatus":null,"regulatoryAction":"recall_ordered","regulatoryBody":"FDA","propertyDamageEstimateUsd":null,"damageEstimateBasis":null,"bodilyInjurySeverity":null,"fatalityCount":null,"lossCostClass":null,"sourceQualityTier":null,"oshaRecordable":null,"oshaCaseNumber":null,"rootCauseDisclosed":null,"publicDisclosureDate":null,"insuranceClaimPublic":null,"formFactor":"surgical","latitude":{"s":1,"e":1,"d":[48,7921100]},"longitude":{"s":1,"e":0,"d":[2,3633050]},"autonomyClass":null,"legalOutcomeClass":"unknown","createdAt":"2026-07-06T15:07:24.028Z","updatedAt":"2026-07-21T23:41:53.660Z","model":{"id":"ba28973f-6a33-4cce-a22f-d34a99443937","companyId":"cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed","modelName":"Epione","slug":"epione","description":"French medical robotics company developing the [Epione](/models/epione) robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former [Medtech SA](/companies/medtech-sa) engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.quantumsurgical.com/news/fda-clears-quantum-surgicals-epione-robot-for-all-abdominal-cancers","title":"FDA clears Quantum Surgical's Epione robot for all abdominal cancers","sourceName":"Quantum Surgical"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"abdominal ablation indication"},{"label":"CE marked","value":"abdomen, chest, musculoskeletal"},{"label":"Acquired NeuWave Medical","value":"Feb 2026"},{"label":"CEO","value":"Bertin Nahum (President & Co-founder)"},{"label":"Group CEO","value":"Kurt Azarbarzin (Precision IO Group, appointed Feb 2026)"},{"label":"Co-founders","value":"Bertin Nahum, Fernand Badano, Lucien Blondel, Sophie Roca"},{"label":"Total funding","value":"approx 90M USD (50M EUR equity + 30M EUR EIB loan)"},{"label":"FDA clearance","value":"510(k) K223758 for abdominal tumor ablation"},{"label":"CE mark","value":"abdomen, lung, and musculoskeletal indications"},{"label":"Parent company","value":"Precision IO Group Inc. (since Feb 2026)"},{"label":"Patients treated","value":"1400+ (as of 2026)"}],"createdAt":"2026-07-06T14:11:34.647Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null},"deployment":{"id":"3c35444a-6010-458e-b1e4-76fd2f5b572d","modelId":"ba28973f-6a33-4cce-a22f-d34a99443937","versionId":null,"locationId":"f202112c-5a59-4e4d-a258-b5744ac5dda0","operatorId":"cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed","ownerId":null,"slug":"epione-leeds-uk","status":"operational","firstSeen":"2025-12-04T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.quantumsurgical.com/news","label":"Leeds Teaching Hospitals Acquires Epione","title":"Leeds Teaching Hospitals Acquires Epione","mediaType":"article","sourceName":"Quantum Surgical","publishedAt":"2025-12-04"}],"notes":"Leeds Teaching Hospitals NHS Trust acquired Epione, became fastest-adopting center with 25+ patients treated.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-07-06T15:23:32.992Z","updatedAt":"2026-08-21T14:21:49.299Z"},"company":{"id":"cb6a0ecc-6b4d-486d-9356-ea9c928ba0ed","name":"Quantum Surgical","slug":"quantum-surgical","description":"French medical robotics company developing the [Epione](/models/epione) robotic platform for CT-guided percutaneous tumor ablation, enabling minimally invasive treatment of abdominal, lung, and bone cancers. Founded in 2017 by a team of former [Medtech SA](/companies/medtech-sa) engineers led by Bertin Nahum, the company is headquartered in Montpellier with a US subsidiary in Miami. Now part of Precision IO Group after acquiring NeuWave Medical in February 2026, with over 1,400 patients treated across Europe and the United States.","status":"private","founded":2017,"hq":"Montpellier, France","hqLat":43.6112422,"hqLng":3.8767337,"hqGeocodedAt":"2026-08-05T14:44:25.158Z","hqAddress":null,"hqPrecision":null,"website":"quantumsurgical.com","fundingTotal":"86923000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.quantumsurgical.com/news/fda-clears-quantum-surgicals-epione-robot-for-all-abdominal-cancers","title":"FDA clears Quantum Surgical's Epione robot for all abdominal cancers","sourceName":"Quantum Surgical"}],"keyFacts":[{"label":"FDA cleared","value":"abdominal ablation indication"},{"label":"CE marked","value":"abdomen, chest, musculoskeletal"},{"label":"Acquired NeuWave Medical","value":"Feb 2026"},{"label":"CEO","value":"Bertin Nahum (President & Co-founder)"},{"label":"Group CEO","value":"Kurt Azarbarzin (Precision IO Group, appointed Feb 2026)"},{"label":"Co-founders","value":"Bertin Nahum, Fernand Badano, Lucien Blondel, Sophie Roca"},{"label":"Total funding","value":"approx 90M USD (50M EUR equity + 30M EUR EIB loan)"},{"label":"FDA clearance","value":"510(k) K223758 for abdominal tumor ablation"},{"label":"CE mark","value":"abdomen, lung, and musculoskeletal indications"},{"label":"Parent company","value":"Precision IO Group Inc. (since Feb 2026)"},{"label":"Patients treated","value":"1400+ (as of 2026)"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":140,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-06T14:11:34.262Z","updatedAt":"2026-08-21T22:24:34.923Z"},"derived":{"status":"active"},"sources":[{"id":"5e14fc01-91e4-4ea6-a56e-b63003e6b6b3","incidentId":"622ce5ab-b136-479d-8631-33ec3aa0491e","url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=209707","label":null,"publishedAt":null,"notes":null,"title":"Class 2 Device Recall QUANTUM Surgical EPIONE","sourceName":"FDA Recall Database","mediaType":"article","videoId":null,"channel":null,"durationSec":null,"timestampSec":null,"createdAt":"2026-07-06T15:07:24.416Z","updatedAt":"2026-07-06T15:07:24.416Z"},{"id":"d663a035-c0e5-4b15-a3f7-5d43c4980d8b","incidentId":"622ce5ab-b136-479d-8631-33ec3aa0491e","url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?event_id=95194&start_search=1","label":null,"publishedAt":null,"notes":null,"title":"Medical Device Recall event 95194: Quantum Surgical EPIONE","sourceName":"U.S. Food and Drug Administration","mediaType":"article","videoId":null,"channel":null,"durationSec":null,"timestampSec":null,"createdAt":"2026-09-29T22:12:30.627Z","updatedAt":"2026-09-29T22:12:30.627Z"},{"id":"497c5f1c-1cf0-4e5c-aa0d-9d251b6e2dcf","incidentId":"622ce5ab-b136-479d-8631-33ec3aa0491e","url":"https://ansm.sante.fr/informations-de-securite/chirurgie-assistee-par-ordinateur-guide-aguille-needle-guide-robot-epione-quantum-surgical","label":null,"publishedAt":null,"notes":null,"title":"Chirurgie assistée par ordinateur, guide aiguille Needle Guide robot Epione","sourceName":"Agence nationale de sécurité du médicament et des produits de santé","mediaType":"article","videoId":null,"channel":null,"durationSec":null,"timestampSec":null,"createdAt":"2026-09-29T22:13:47.780Z","updatedAt":"2026-09-29T22:13:47.780Z"}],"responses":[],"statusEvents":[{"id":"695baae6-77ae-4976-9c73-cd71c10d2103","incidentId":"622ce5ab-b136-479d-8631-33ec3aa0491e","status":"active","reason":null,"source":"agent:depth","effectiveAt":"2026-07-06T15:07:24.796Z","createdAt":"2026-07-06T15:07:24.798Z"}],"jsonLd":{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://registry.deploy.report/incidents/recall-2024-08-05-quantum-surgical","url":"https://registry.deploy.report/incidents/recall-2024-08-05-quantum-surgical","headline":"FDA Class 2 recall of Epione needle guide component due to rust","description":"Quantum Surgical issued an urgent field safety notice for 2 Epione units in Florida after discovering rust on a component (central axis) inside the Needle Guide product (product number 02-0027). The affected units were returned, repaired, and replaced. Recall was completed by October 2024.","identifier":"622ce5ab-b136-479d-8631-33ec3aa0491e","datePublished":"2024-08-05T12:00:00.000Z","articleSection":"recall","publisher":{"@id":"https://deploy.report/#organization"},"author":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-fda-database"]}}}